Terry Sherraden
Tallahassee, FLNPI 1629003207
Payments from drug & device makers
$1,805in general payments, 2019–2025
Across 75 payments — averaging $24.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$285
- Lilly USA, LLC$272
- Amgen$247
- Abbott$159
- AstraZeneca$145
- Valeritas, Inc.$125
- plus $572 from 15 others
What the payments were for
- Food & beverage$1,78099%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 9 | $285 |
| Lilly USA, LLC | 7 | $272 |
| Amgen(2 entities) | 7 | $247 |
| Abbott | 8 | $159 |
| AstraZeneca | 6 | $145 |
| Valeritas, Inc. | 3 | $125 |
| Boehringer Ingelheim | 5 | $92 |
| Merck | 6 | $80 |
| Novo Nordisk | 5 | $75 |
| Johnson & Johnson | 5 | $71 |
| Sanofi Pasteur Inc. | 1 | $60 |
| AbbVie | 3 | $45 |
| Tandem Diabetes Care, Inc. | 2 | $33 |
| Radius Health, Inc. | 1 | $19 |
| Companion Medical, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| Lifescan, Inc. | 1 | $13 |
| Medtronic | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.